De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a network meta-analysis of randomised controlled trials
- 8 July 2021
- journal article
- review article
- Published by Wiley in Emergencias
- Vol. 2021 (7)
- https://doi.org/10.1002/14651858.cd014813
Abstract
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: The objective of this review is to evaluate the available evidence in order to identify an optimal de‐escalation strategy in terms of duration and type of therapy for patients with ACS treated with PCI. We will perform a NMA to appraise the safest and most efficacious combination of type and length of DAPT de‐escalation.Keywords
This publication has 44 references indexed in Scilit:
- Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trialEuropean Heart Journal, 2011
- Comparison of Mortality Rates in Women Versus Men Presenting With ST-Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2011
- CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control studyEuropean Heart Journal, 2010
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLoS Medicine, 2009
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 2007
- The truly remarkable universality of half a standard deviation: confirmation through another lookExpert Review of Pharmacoeconomics & Outcomes Research, 2004
- Clopidogrel for Coronary StentingCirculation, 2003
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsThe New England Journal of Medicine, 1989